Search Results - "Harrap, Kenneth R."

Refine Results
  1. 1

    Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV) : an orally active platinum drug by KELLAND, L. R, ABEL, G, MCKEAGE, M. J, JONES, M, GODDARD, P. M, VALENTI, M, MURRER, B. A, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (01-06-1993)
    “…The cytotoxicity of a novel platinum(IV) complex, bis-acetato-amminedichloro-cyclohexylamine platinum(IV) (JM216), has been evaluated in vitro against a panel…”
    Get full text
    Journal Article
  2. 2

    A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity by KELLAND, L. R, BARNARD, C. F. J, MELLISH, K. J, JONES, M, GODDARD, P. M, VALENTI, M, BRYANT, A, MURRER, B. A, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (01-11-1994)
    “…As part of a drug discovery program to discover more effective platinum-based anticancer drugs, a series of platinum complexes of trans coordination geometry…”
    Get full text
    Journal Article
  3. 3

    Ammine/amine platinum(IV) dicarboxylates : a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines by KELLAND, L. R, MURRER, B. A, ABEL, G, GIANDOMENICO, C. M, MISTRY, P, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (15-02-1992)
    “…Using a panel of six human ovarian carcinoma cell lines varying by two orders of magnitude in terms of cisplatin cytotoxicity, we have investigated the in…”
    Get full text
    Journal Article
  4. 4

    Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues by Leyland-Jones, Brian, Kelland, Lloyd R., Harrap, Kenneth R., Hiorns, Lynne R.

    Published in The American journal of pathology (01-07-1999)
    “…During the past several years, a panel of human tumor cell lines (predominantly ovarian) with acquired resistance to cisplatin, the orally bioavailable…”
    Get full text
    Journal Article
  5. 5

    Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line by KELLAND, L. R, MISTRY, P, ABEL, G, FREIDLOS, F, LOH, S. Y, ROBERTS, J. J, HARRAP, K. R

    Published in Cancer research (Baltimore) (01-04-1992)
    “…Clinically, human testicular nonseminomatous germ cell tumors exhibit remarkable sensitivity to platinum-based chemotherapy. To define better the mechanistic…”
    Get full text
    Conference Proceeding Journal Article
  6. 6

    Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo by MCKEAGE, J. M, KELLAND, L. R, BOXALL, F. E, VALENTI, M. R, JONES, M, GODDARD, P. M, GWYNNE, J, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (01-08-1994)
    “…JM216 is a novel antitumor platinum(IV) complex displaying oral activity, dose-limiting myelosuppression, and a lack of nephro- and neurotoxicity in rodents…”
    Get full text
    Journal Article
  7. 7

    Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat by MCKEAGE, M. J, BOXALL, F. E, JONES, M, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (01-02-1994)
    “…This study compared the effect on sensory nerve conduction velocity in the hind limb of chronically treated age-matched rats of a novel lipophilic p.o…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function by HARLAND, S. J, NEWELL, D. R, SIDDIK, Z. H, CHADWICK, R, CALVERT, A. H, HARRAP, K. R

    Published in Cancer research (Chicago, Ill.) (01-04-1984)
    “…cis-Diammine-1,1-cyclobutane dicarboxylate platinum(II) (CBDCA, JM8) is a nonnephrotoxic analogue of cisplatin currently undergoing clinical evaluation…”
    Get full text
    Journal Article
  9. 9

    The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats by Siddik, Z H, Newell, D R, Boxall, F E, Harrap, K R

    Published in Biochemical pharmacology (15-06-1987)
    “…The plasma, urinary and biliary clearances of cisplatin and its non-nephrotoxic analogue, Carboplatin (cis-diammine-1,1-cyclobutane dicarboxylate platinum II,…”
    Get more information
    Journal Article
  10. 10

    Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives by Serafinowski, Pawel, Dorland, Erwin, Harrap, Kenneth R, Balzarini, Jan, De Clercq, Erik

    Published in Journal of medicinal chemistry (01-11-1992)
    “…A series of new S-adenosyl-L-homocysteine (AdoHcy) analogues with modifications to amino acid and nucleoside moieties was prepared via condensation of…”
    Get full text
    Journal Article
  11. 11

    Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide by Siddik, Z H, Boxall, F E, Harrap, K R

    Published in Analytical biochemistry (15-05-1987)
    “…Processing biological samples by solubilization in Hyamine hydroxide (methylbenzethonium hydroxide) as an alternative to wet ashing with concentrated nitric…”
    Get more information
    Journal Article
  12. 12

    Dinucleotide analogs as inhibitors of thymidine kinase, thymidylate kinase and ribonucleotide reductase by Davies, Lawrence C, Stock, John A, Barrie, S. Elaine, Orr, Rosanne M, Harrap, Kenneth R

    Published in Journal of medicinal chemistry (01-07-1988)
    “…P1-(Adenosine-5')-Pn-(thymidine-5') tri-, tetra-, penta-, and hexaphosphates (ApnT) plus the analogues with a methylene group alpha, beta to the thymidine…”
    Get full text
    Journal Article
  13. 13

    Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modifications by Jones, Terence R, Smithers, Michael J, Taylor, Michael A, Jackman, Ann L, Calvert, A. Hilary, Harland, Stephen J, Harrap, Kenneth R

    Published in Journal of medicinal chemistry (01-04-1986)
    “…Four new analogues of the antifolate N10-propargyl-5,8-dideazafolic acid were prepared that were substituted in the benzoyl ring. The 2'-chloro and 2'-methyl…”
    Get full text
    Journal Article
  14. 14

    Quinazoline antifolates inhibiting thymidylate synthase. Variation of the amino acid by Jones, Terence R, Smithers, Michael J, Betteridge, Richard F, Taylor, Michael A, Jackman, Ann L, Calvert, A. Hilary, Davies, Lawrence C, Harrap, Kenneth R

    Published in Journal of medicinal chemistry (01-06-1986)
    “…Five new analogues (1c-g) of the antifolate N10-propargyl-5,8-dideazafolic acid (1a) are described in which the benzoyl-L-glutamate moiety was replaced by…”
    Get full text
    Journal Article
  15. 15

    Enhancement of the nuclear reactivity of alkylating agents by prednisolone by Wilkinson, R, Birbeck, M S, Harrap, K R

    Published in Cancer research (Chicago, Ill.) (01-10-1979)
    “…We have compared the nuclear reactions of the alkylating agents chlorambucil, melphalan, and cyclophosphamide used alone, with those produced when the same…”
    Get full text
    Journal Article
  16. 16

    A reappraisal of the effect upon thymidine kinase of thymidine derivatives carrying large groups at the 5'-position by Barrie, S. Elaine, Davies, Lawrence C, Stock, John A, Harrap, Kenneth R

    Published in Journal of medicinal chemistry (01-08-1984)
    “…Several thymidine derivatives with hydrophobic 5'-substituents, linked by chemically stable amide and ether links, were synthesized as potential thymidine…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines by ORMEROD, M. G, O'NEILL, C, ROBERTSON, D, KELLAND, L. R, HARRAP, K. R

    “…We have studied the effects of the chemotherapeutic drug cis-diamminedichloroplatinum(II) (cis-platin) on three human ovarian carcinoma cell lines - one…”
    Get full text
    Journal Article
  20. 20

    A phase I and pharmacology study of an oral platinum complex, JM216 : dose-dependent pharmacokinetics with single-dose administration by MCKEAGE, M. J, PRAKASH MISTRY, SANTABARBARA, P, HARRAP, K. R, JUDSON, I. R, WARD, J, BOXALL, F. E, SWEE LOH, O'NEILL, C, ELLIS, P, KELLAND, L. R, MORGAN, S. E, MURRER, B

    “…JM216 [bis-acetato-ammine-dichloro-cyclo-hexylamine-platinum (IV)] is an oral platinum complex with in vivo activity against murine and human tumor models and…”
    Get full text
    Journal Article